These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 2553315)
1. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP. Wulfrank DA; Schelstraete KH; Small F; Fallais CJ Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy. Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996 [TBL] [Abstract][Full Text] [Related]
3. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma. Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148 [TBL] [Abstract][Full Text] [Related]
4. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis. Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans. Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320 [TBL] [Abstract][Full Text] [Related]
6. 99mTc(V)-DMSA and 99mTc-MDP uptake and no 67Ga-citrate uptake in a case of primary pulmonary leiomyosarcoma. Ohta H; Komibuchi T; Nishiyama H; Shizuki K; Miyaki Y Ann Nucl Med; 1992 Aug; 6(3):191-3. PubMed ID: 1327043 [TBL] [Abstract][Full Text] [Related]
7. Poor renal uptake of technetium-99m-DMSA and technetium-99m-MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate. Kim SE; Cho JT; Lee DS; Chung JK; Kim S; Lee MC; Lee JS; Koh CS J Korean Med Sci; 1994 Feb; 9(1):29-34. PubMed ID: 8068216 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid. Lam AS; Puncher MR; Blower PJ Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310 [TBL] [Abstract][Full Text] [Related]
9. Poor renal uptake of Tc-99m DMSA and Tc-99m MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate. Kim SE; Cho JT; Lee DS; Chung JK; Kim S; Lee MC; Lee JS; Koh CS Clin Nucl Med; 1995 Mar; 20(3):215-9. PubMed ID: 7750213 [TBL] [Abstract][Full Text] [Related]
10. Increased bone marrow uptake on Tc-99m DMSA scintigraphy in a patient with renal osteodystrophy. Caglar M; Naldöken S Ann Nucl Med; 1993 Nov; 7(4):281-3. PubMed ID: 8292457 [TBL] [Abstract][Full Text] [Related]
11. Incidental visualization of hepatic hemangioma during Tc-99m (v) DMSA, Tl-201, and Tc-99m MDP imaging. Adalet I; Kocak M; Oguz H; Alagol F; Cantez S Clin Nucl Med; 1995 Dec; 20(12):1106-7. PubMed ID: 8674308 [No Abstract] [Full Text] [Related]
12. Uptake of pentavalent technetium-99m dimercaptosuccinic acid in idiopathic synovial chondromatosis. Kobayashi H; Kotoura Y; Hosono M; Tsuboyama T; Nishijima N; Sakahara H; Konishi J Ann Nucl Med; 1995 Aug; 9(3):153-5. PubMed ID: 8534590 [TBL] [Abstract][Full Text] [Related]
13. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging. Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696 [TBL] [Abstract][Full Text] [Related]
15. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA. Yen TC; King KL; Yang AH; Liu RS; Yeh SH J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions. Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327 [TBL] [Abstract][Full Text] [Related]
17. [Local findings of renal cell carcinoma on 99m-Tc-DMSA renal, 99m-Tc-MDP bone and 67-Ga-citrate scintigraphies]. Kawamura J; Itoh H; Yoshida O; Fujita T; Fukunaga M; Morita R; Torizuka K Kaku Igaku; 1982 Apr; 19(3):357-68. PubMed ID: 6290720 [No Abstract] [Full Text] [Related]
18. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions. Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845 [TBL] [Abstract][Full Text] [Related]
19. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy. Yüksel D; Ilgan S; Arslan N; Uğur O; Oztürk E; Bayhan H Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416 [TBL] [Abstract][Full Text] [Related]
20. Pentavalent technetium-99m DMSA uptake in pseudofractures of osteomalacia. Sahin M; Basoglu T; Albayrak S; Canbaz F; Yapici O Clin Nucl Med; 2001 Jan; 26(1):62-4. PubMed ID: 11139060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]